Polyvinylpyrrolidone Market to Reach USD 2.64 Billion by 2032 Amid Rising Demand from Healthcare & FMCG Sectors

Polyvinylpyrrolidone Market to Reach USD 2.64 Billion by 2032 Amid Rising Demand from Healthcare & FMCG Sectors

As per MRFR analysis, the Polyvinylpyrrolidone (PVP) Market Size was estimated at USD 1.69 Billion in 2024. The Polyvinylpyrrolidone industry is projected to grow from USD 1.787 Billion in 2025 to USD 3.114 Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.71% during the forecast period (2025–2035).

MRFR recognizes the following companies as the key players in the Global Polyvinylpyrrolidone (PVP) Market, BASF SE (Germany), Ashland Global Holdings Inc. (US), Kraton Corporation (US), Merck KGaA (Germany), Luvata (Finland), Wacker Chemie AG (Germany), JRS Pharma (Germany), GAF Materials Corporation (US), and Kao Corporation (Japan).

Polyvinylpyrrolidone (PVP) Market Highlights

The Global Polyvinylpyrrolidone Market was valued at USD 1.69 Billion in 2024 and is projected to reach USD 3.114 Billion by 2035, growing at a CAGR of 5.71% during 2025–2035.

Polyvinylpyrrolidone (PVP) is a versatile, water-soluble polymer extensively used in pharmaceuticals, cosmetics, food, and adhesives industries due to its exceptional solubility, biocompatibility, and stabilizing properties. It functions as a binder, emulsifier, and film-forming agent, making it indispensable across diverse industrial applications.

Market growth is being driven by increasing demand for high-performance excipients in drug formulations, expanding usage in personal care and cosmetics, and growing innovation in manufacturing processes. Additionally, the trend toward sustainable and eco-friendly chemical formulations is further propelling the adoption of PVP across various sectors.

Segment Analysis

The Global Polyvinylpyrrolidone (PVP) Market has been segmented based on Grade and Application.

Based on Grade: PVP K-15, PVP K-30, PVP K-60, and Others, The PVP K-30 segment dominates the market, attributed to its superior solubility, stability, and binding strength in pharmaceutical formulations and personal care applications.

It remains the preferred grade for drug delivery systems and cosmetics manufacturing.The PVP K-60 segment is projected to be the fastest-growing, driven by its viscosity and film-forming properties, particularly in skincare and industrial formulations. With ongoing product innovation and tailored molecular weight development, both pharmaceutical and cosmetic manufacturers are increasingly shifting toward customized grades of PVP.

Based on Application: Pharmaceuticals, Cosmetics, Food & Beverage, Adhesives, and Others. The Pharmaceuticals segment leads the market, accounting for the largest share in 2024. PVP’s role as a binder, dispersant, and solubilizer in tablet formulations and drug delivery systems continues to underpin demand. The Cosmetics segment is anticipated to experience the fastest growth, supported by the rising trend of premium skincare, haircare, and personal hygiene products. In the Food & Beverage sector, PVP is gaining traction as a clarifying and stabilizing agent, while the Adhesives segment benefits from its excellent film-forming and adhesive characteristics.

Regional Analysis

The Global Polyvinylpyrrolidone Market, based on region, has been divided into North America, Europe, Asia-Pacific, and Rest of the World (RoW).

North America holds the largest market share (~40%), led by the United States, which accounts for nearly 60% of the regional market. The dominance of this region stems from the widespread use of PVP in pharmaceutical formulations, coupled with strong regulatory support from the U.S. Food and Drug Administration (FDA). The presence of major players such as BASF SE, Ashland Global Holdings Inc., and Kraton Corporation further drives innovation and supply chain strength in the region.

Europe represents approximately 30% of the global market, driven by stringent regulatory standards and the growing preference for biocompatible and sustainable polymers. Germany and France lead the regional market, supported by robust pharmaceutical and cosmetics industries. Key manufacturers like Merck KGaA and Wacker Chemie AG are investing heavily in R&D, particularly in high-purity PVP formulations for drug delivery and dermo-cosmetic applications. The European Green Deal continues to influence the shift toward eco-conscious production methods.

The Asia-Pacific region is the fastest-growing market, projected to expand significantly through 2035. Countries such as China, Japan, and India are witnessing rapid industrialization, urbanization, and increased healthcare expenditure. Rising consumer demand for cosmetics, expanding pharmaceutical production capacities, and government support for sustainable chemical manufacturing are key growth drivers. Leading companies like Kao Corporation and Wanhua Chemical Group are actively expanding production facilities to cater to this increasing regional demand.

The Rest of the World region holds around 5% of the global share. Growth is primarily driven by the expanding pharmaceutical and healthcare sectors in UAE, South Africa, and Brazil. Strategic investments by companies like GAF Materials Corporation are supporting regional diversification and capacity building. The focus on industrial expansion and infrastructure development is expected to create new growth opportunities for PVP applications across healthcare and food industries.

Key Findings of the Study

• The Global Polyvinylpyrrolidone (PVP) Market is projected to reach USD 3.114 Billion by 2035, at a CAGR of 5.71% during 2025–2035.


• The PVP K-30 grade holds the largest market share, while PVP K-60 is emerging as the fastest-growing grade segment.


• The Pharmaceuticals application segment dominates the market, while Cosmetics is the most rapidly expanding category.


• North America leads the global market, while Asia-Pacific is the fastest-growing region.


• Rising demand for biocompatible and sustainable polymers is driving innovation and product diversification.


• Key players include BASF SE, Ashland Global Holdings Inc., Merck KGaA, Kraton Corporation, Wacker Chemie AG, JRS Pharma, and Kao Corporation.